CMN1 Stock Chart & Stats
€6.44
-€0.09(-1.18%)
At close: 4:00 PM EDT
€6.44
-€0.09(-1.18%)
Day’s Range― - ―
52-Week Range€5.15 - €7.47
Previous CloseN/A
Volume0.00
Average Volume (3M)94.00
Market Cap
€1.68B
Enterprise Value€1.59K
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€189.20M
Price to Earnings (P/E)43.5
Beta1.08
Next Earnings
Dec 15, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding272,126,800
10 Day Avg. Volume0
30 Day Avg. Volume94
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)4.06
Price to Sales (P/S)3.12
P/FCF Ratio-277.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.70Price Target Upside19.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€6.45M
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilityImproving net profit, EBIT and EBITDA margins indicate stronger operating efficiency and provide a more resilient earnings base. If sustained, this can support internal investment and profitability across government-focused programs.
Manageable LeverageModerate leverage and a substantial equity funding base give Chemring financial flexibility to support defense production, research and development, and contract execution without excessive dependence on additional borrowing.
Strong Operating Cash ConversionOperating cash flow materially exceeds reported net income, suggesting that the core business can convert accounting earnings into cash. This supports ongoing operations and indicates a useful underlying cash-generation capability.
Bears Say
Declining RevenueFalling revenue points to weaker recent demand or contract timing and can limit operating leverage. Persistent top-line contraction would make it harder to sustain margin gains and grow Chemring’s defense technology business.
Earnings ContractionThe sharp decline in earnings per share signals pressure on shareholder-level earnings despite improved reported margins. If this reflects weaker volumes or program mix, it could constrain investment capacity and long-term earnings momentum.
Free Cash Flow PressureNegative free cash flow relative to earnings indicates that capital expenditure, working capital or other cash demands are absorbing operating cash. Sustained pressure could reduce funding flexibility for expansion and contract delivery.
Chemring News
CMN1 FAQ
What was Chemring’s price range in the past 12 months?
Chemring lowest stock price was €5.15 and its highest was €7.46 in the past 12 months.
What is Chemring’s market cap?
Chemring’s market cap is €1.68B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 15, 2026 which is in 92 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported €0.071 earnings per share for the quarter.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.16.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of €0.071 in its last earnings report. Following the earnings report the stock price went down -5.493%.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in DE:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemring Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€7.70 (19.60% Upside)
€7.70 (19.60% Upside)
Insider Transactions
Sold Shares
Worth €1.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.49%
12-Months-Change
Fundamentals
Return on Equity
1.61%
Trailing 12-Months
Asset Growth
20.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chemring
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Information segments provides consulting and technology services to solve security-critical issues. The Countermeasures & Energetics segment comprises of development and manufacture of expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators, and energetic materials. The company was founded on November 30, 1905 and is headquartered in Romsey, the United Kingdom.
CMN1 Stock 12 Month Forecast
Average Price Target
€7.70
▲(19.60% Upside)